Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crane is a synthetic biology company developing a foundational platform to program cells with high precision and predictability. By creating what it describes as a "biological operating system," the company aims to streamline the design and engineering of complex biological systems for therapeutic and industrial applications. Their technology focuses on bridging the gap between computational design and biological execution, enabling the development of next-generation cell and gene therapies. Crane's approach seeks to transform biology into a predictable engineering discipline, significantly reducing the time and cost associated with biological discovery and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crane.